Ivor Royston

This profile gathers the share dealings of Ivor Royston across 5 companies, led by Viracta Therapeutics, Inc., MMRGlobal, Inc. and Avalon Pharmaceuticals Inc. Between 3 January 2006 and 25 November 2024, the trades on record add up to 49 filings.

Both buying and selling appear: 13 purchases worth €7.0M, against 3 sales worth €113k. The amount is not disclosed for 4 filings. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 13 share grants and 16 option exercises.

A typical purchase (the median) is worth €46k.

The record was last updated on 27 November 2024 with an option exercise in Viracta Therapeutics, Inc. The clock since the last published purchase (15 November 2021) now reads 1,804 days. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.